NAVIDEA BIOPHARMACEUTICALS, INC. (24) | Stock Agreements (11)
Recent Contracts
-
Section 382 Rights Agreement, dated as of April 7, 2022, between Navidea Biopharmaceuticals, Inc. and Continental Stock Transfer & Trust Company, LLC, as Rights Agent
(Filed With SEC on April 12, 2022)
-
Amendment to Stock Purchase Agreement and Letter of Investment Intent by and between the Company and Investor dated July 8, 2021
(Filed With SEC on July 13, 2021)
-
Stock Purchase Agreement and Letter of Investment Intent by and between the Company and Investor dated March 2, 2021
(Filed With SEC on March 4, 2021)
-
Stock Purchase Agreement and Letter of Investment Intent, by and between the Company and Keystone
(Filed With SEC on September 2, 2020)
-
Form of Common Stock Purchase Agreement
(Filed With SEC on September 2, 2020)
-
Stock Purchase Agreement, effective August 9, 2020, by and between Navidea Biopharmaceuticals, Inc. and Jubilant Radiopharma
(Filed With SEC on August 12, 2020)
-
Stock Purchase Agreement and Letter of Investment Intent by and between the Company and the Investor
(Filed With SEC on May 12, 2020)
-
Stock Purchase Agreement, effective February 14, 2020, by and between Navidea Biopharmaceuticals, Inc. and Keystone Capital Partners, LLC
(Filed With SEC on March 18, 2020)
-
Stock Purchase Agreement, effective February 14, 2020, by and between Navidea Biopharmaceuticals, Inc. and John K. Scott
(Filed With SEC on March 18, 2020)
-
Stock Purchase Agreement, dated December 6, 2019, among Navidea Biopharmaceuticals, Inc. and the purchasers named therein
(Filed With SEC on December 11, 2019)
-
Stock Purchase Agreement, dated March 22, 2019, between Navidea Biopharmaceuticals, Inc. and John K. Scott, Jr
(Filed With SEC on May 9, 2019)